Back to Search
Start Over
Intermediate-dose cytarabine or standard-dose cytarabine plus single-dose anthracycline as post-remission therapy in older patients with acute myeloid leukemia: impact on health care resource consumption and outcomes
- Source :
- Blood Cancer Journal, Vol 11, Iss 11, Pp 1-4 (2021), Blood Cancer Journal
- Publication Year :
- 2021
- Publisher :
- Springer Science and Business Media LLC, 2021.
- Subjects :
- Male
Oncology
medicine.medical_specialty
Anthracycline
Acute myeloid leukaemia
Older patients
Internal medicine
Correspondence
Antineoplastic Combined Chemotherapy Protocols
Health care
medicine
Humans
Anthracyclines
Registries
Resource consumption
RC254-282
Aged
business.industry
Remission Induction
Cytarabine
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Myeloid leukemia
Hematology
Middle Aged
Leukemia, Myeloid, Acute
Female
business
medicine.drug
Subjects
Details
- ISSN :
- 20445385
- Volume :
- 11
- Database :
- OpenAIRE
- Journal :
- Blood Cancer Journal
- Accession number :
- edsair.doi.dedup.....1371acb4febb058a0b0726f877356b06
- Full Text :
- https://doi.org/10.1038/s41408-021-00551-y